Vera Schäffer

420 total citations
8 papers, 336 citations indexed

About

Vera Schäffer is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Vera Schäffer has authored 8 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Cancer Research and 1 paper in Oncology. Recurrent topics in Vera Schäffer's work include MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (3 papers) and Circular RNAs in diseases (2 papers). Vera Schäffer is often cited by papers focused on MicroRNA in disease regulation (6 papers), Cancer-related molecular mechanisms research (3 papers) and Circular RNAs in diseases (2 papers). Vera Schäffer collaborates with scholars based in Germany, Denmark and Spain. Vera Schäffer's co-authors include Marlies Eilers, Britta Skawran, Brigitte Schlegelberger, Maria Sandbothe, Florian Kühnel, Engin Gürlevik, R. Buurman, Hans Kreipe, Ludwig Wilkens and Thomas Illig and has published in prestigious journals such as Gastroenterology, International Journal of Molecular Sciences and Journal of Hepatology.

In The Last Decade

Vera Schäffer

8 papers receiving 335 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vera Schäffer Germany 6 281 212 41 27 22 8 336
Marlies Eilers Germany 6 281 1.0× 212 1.0× 41 1.0× 27 1.0× 22 1.0× 8 336
Shoumei Yang China 6 225 0.8× 172 0.8× 48 1.2× 17 0.6× 11 0.5× 8 296
Mujian Teng China 10 227 0.8× 164 0.8× 62 1.5× 40 1.5× 22 1.0× 11 335
Xuetao Shi China 9 174 0.6× 147 0.7× 45 1.1× 16 0.6× 38 1.7× 13 292
Liutao Chen China 7 445 1.6× 230 1.1× 51 1.2× 20 0.7× 15 0.7× 7 511
Zhongbo Han China 6 325 1.2× 312 1.5× 37 0.9× 32 1.2× 35 1.6× 13 418
Jiaoyuan Jia China 8 206 0.7× 93 0.4× 36 0.9× 14 0.5× 15 0.7× 10 264

Countries citing papers authored by Vera Schäffer

Since Specialization
Citations

This map shows the geographic impact of Vera Schäffer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vera Schäffer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vera Schäffer more than expected).

Fields of papers citing papers by Vera Schäffer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vera Schäffer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vera Schäffer. The network helps show where Vera Schäffer may publish in the future.

Co-authorship network of co-authors of Vera Schäffer

This figure shows the co-authorship network connecting the top 25 collaborators of Vera Schäffer. A scholar is included among the top collaborators of Vera Schäffer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vera Schäffer. Vera Schäffer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Buurman, R., Maria Sandbothe, Anke K. Bergmann, et al.. (2022). MiR-129-5p exerts Wnt signaling-dependent tumor-suppressive functions in hepatocellular carcinoma by directly targeting hepatoma-derived growth factor HDGF. Cancer Cell International. 22(1). 192–192. 7 indexed citations
2.
Bhowmick, Rahul, Vera Schäffer, Marlies Eilers, et al.. (2022). MicroRNA-449a Inhibits Triple Negative Breast Cancer by Disturbing DNA Repair and Chromatid Separation. International Journal of Molecular Sciences. 23(9). 5131–5131. 7 indexed citations
3.
Eilers, Marlies, Vera Schäffer, Oliver Dittrich‐Breiholz, et al.. (2021). Ago-RIP Sequencing Identifies New MicroRNA-449a-5p Target Genes Increasing Sorafenib Efficacy in Hepatocellular Carcinoma. Journal of Cancer. 13(1). 62–75. 5 indexed citations
4.
Schäffer, Vera, et al.. (2021). MicroRNA‐192‐5p inhibits migration of triple negative breast cancer cells and directly regulates RhoGTPaseactivating protein 19. Genes Chromosomes and Cancer. 60(11). 733–742. 5 indexed citations
5.
Pfister, Eva‐Doreen, Ulrich Baumann, Marlies Eilers, et al.. (2019). Homozygous frame shift variant in ATP7B exon 1 leads to bypass of nonsense-mediated mRNA decay and to a protein capable of copper export. European Journal of Human Genetics. 27(6). 879–887. 4 indexed citations
6.
Sandbothe, Maria, Marlies Eilers, Vera Schäffer, et al.. (2019). Wnt status-dependent oncogenic role of BCL9 and BCL9L in hepatocellular carcinoma. Hepatology International. 14(3). 373–384. 29 indexed citations
7.
Sandbothe, Maria, R. Buurman, Nicole Reich, et al.. (2017). The microRNA-449 family inhibits TGF-β-mediated liver cancer cell migration by targeting SOX4. Journal of Hepatology. 66(5). 1012–1021. 104 indexed citations
8.
Buurman, R., Engin Gürlevik, Vera Schäffer, et al.. (2012). Histone Deacetylases Activate Hepatocyte Growth Factor Signaling by Repressing MicroRNA-449 in Hepatocellular Carcinoma Cells. Gastroenterology. 143(3). 811–820.e15. 175 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026